Search research articles
Contact Us
Filters
Showing results (1-10 of 132) with videos related to
Page
of 14
Sort By:
Bioanalysis
|
May 17, 2018
Endogenous probes for human liver organic anion-transporting polypeptides: the intersection of bioanalytical and ADME science
A David Rodrigues
Drug Metabolism Letters
|
April 10, 2009
Prioritization of clinical drug interaction studies using in vitro cytochrome P450 data: proposed refinement and expansion of the "rank order" approach
A David Rodrigues
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 25, 2005
Impact of CYP2C9 genotype on pharmacokinetics: are all cyclooxygenase inhibitors the same?
A David Rodrigues
Clinical Pharmacology and Therapeutics
|
August 3, 2021
Drug Interactions Involving 17α-Ethinylestradiol: Considerations Beyond Cytochrome P450 3A Induction and Inhibition
A David Rodrigues
Current Protocols in Pharmacology
|
October 1, 2011
Cytochrome p450 assays
Enock Delaporte, A David Rodrigues
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 24, 2004
Is 17alpha-ethinyl estradiol an inhibitor of cytochrome P450 2C19?
A David Rodrigues, Ping Lu
Journal of Clinical Pharmacology
|
March 4, 2010
Does the long plasma half-life of 4beta-hydroxycholesterol impact its utility as a cytochrome P450 3A (CYP3A) metric?
Zheng Yang, A David Rodrigues
The Journal of Pharmacology and Experimental Therapeutics
|
December 28, 2019
Profiling of Drug-Metabolizing Enzymes and Transporters in Human Tissue Biopsy Samples: A Review of the Literature
A David Rodrigues, Andrew Rowland
Current Drug Metabolism
|
June 27, 2002
Cytochrome P450 pharmacogenetics in drug development: in vitro studies and clinical consequences
A David Rodrigues, Thomas H Rushmore
Methods in Molecular Biology (Clifton, N.J.)
|
December 2, 2009
Examination of CYP3A and P-glycoprotein-mediated drug-drug interactions using animal models
Punit H Marathe, A David Rodrigues
Page
of 14
Search research articles
Search
Showing results (1-10 of 132) with videos related to
Sort By:
Page
of 14
Bioanalysis
|
May 17, 2018
Endogenous probes for human liver organic anion-transporting polypeptides: the intersection of bioanalytical and ADME science
A David Rodrigues
Drug Metabolism Letters
|
April 10, 2009
Prioritization of clinical drug interaction studies using in vitro cytochrome P450 data: proposed refinement and expansion of the "rank order" approach
A David Rodrigues
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 25, 2005
Impact of CYP2C9 genotype on pharmacokinetics: are all cyclooxygenase inhibitors the same?
A David Rodrigues
Clinical Pharmacology and Therapeutics
|
August 3, 2021
Drug Interactions Involving 17α-Ethinylestradiol: Considerations Beyond Cytochrome P450 3A Induction and Inhibition
A David Rodrigues
Current Protocols in Pharmacology
|
October 1, 2011
Cytochrome p450 assays
Enock Delaporte, A David Rodrigues
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 24, 2004
Is 17alpha-ethinyl estradiol an inhibitor of cytochrome P450 2C19?
A David Rodrigues, Ping Lu
Journal of Clinical Pharmacology
|
March 4, 2010
Does the long plasma half-life of 4beta-hydroxycholesterol impact its utility as a cytochrome P450 3A (CYP3A) metric?
Zheng Yang, A David Rodrigues
The Journal of Pharmacology and Experimental Therapeutics
|
December 28, 2019
Profiling of Drug-Metabolizing Enzymes and Transporters in Human Tissue Biopsy Samples: A Review of the Literature
A David Rodrigues, Andrew Rowland
Current Drug Metabolism
|
June 27, 2002
Cytochrome P450 pharmacogenetics in drug development: in vitro studies and clinical consequences
A David Rodrigues, Thomas H Rushmore
Methods in Molecular Biology (Clifton, N.J.)
|
December 2, 2009
Examination of CYP3A and P-glycoprotein-mediated drug-drug interactions using animal models
Punit H Marathe, A David Rodrigues
Page
of 14